Sign in

CIK 0001528287

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

NeuroPace Inc

Sign in to watch
Ticker
NPCE
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
223550230
Phone
+1 650-237-2700
Business address
455 N. BERNARDO AVENUE, MOUNTAIN VIEW, CA, 94043
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-04-26 Favet Michael Chief Executive Officer Conversion · Series A' Preferred Stock −343 0
2021-04-26 Favet Michael Chief Executive Officer Conversion · Series B' Preferred Stock −7,219 0
2021-04-26 LACOB JOSEPH Director Grant or award +334,027 351,920
2021-04-26 LACOB JOSEPH Director Conversion · Series A' Preferred Stock −8,594 0
2021-04-26 LACOB JOSEPH Director Conversion · Series A' Preferred Stock −17,189 0
2021-04-26 LACOB JOSEPH Director Conversion · Series B; Preferred Stock −102,747 0
2021-04-26 LACOB JOSEPH Director Conversion · Series B' Preferred Stock −205,497 0
2021-04-26 KCK LTD. 10% owner Conversion +5,595,493 5,621,111
2021-04-26 KCK LTD. 10% owner Conversion · Series A' Prime Preferred Stock −323,591 0
2021-04-26 KCK LTD. 10% owner Conversion · Series B' Prime Preferred Stock −5,271,902 0
2021-04-21 Ryan Renee Director Grant or award · Stock Option (Right to Buy) +21,698 21,698
2021-04-21 Norton Evan Director Grant or award · Stock Option (Right to Buy) +21,698 21,698
2021-04-21 Kumar Rakhi Director Grant or award · Stock Option (Right to Buy) +21,698 21,698
2021-04-21 LACOB JOSEPH Director Grant or award · Stock Option (Right to Buy) +21,698 21,698
2021-04-21 ORBIMED ADVISORS LLC 10% owner Purchase +235,000 $17.00 $4.0M 235,000
2021-04-21 Ridley Irina General Counsel and Secretary Purchase +2,352 $17.00 $40K 2,352
2021-04-21 Accelmed Partners II L.P. 10% owner Purchase +588,235 $17.00 $10.0M 588,235
2021-04-21 Fischer Frank M Director Purchase +50,000 $17.00 $850K 93,291
2021-04-21 Fischer Frank M Director Grant or award · Stock Option (Right to Buy) +21,698 21,698
2021-04-21 Garfield Greg Shaw Director Purchase +13,235 $17.00 $225K 38,853

Page 18 of 19 · 362 trades